During my recent chat on The Healthtech Podcast, I spoke candidly about the important aspects of health economics and why technologies (especially AI), need meticulous evaluation to ensure not only patient safety, but value for money.

In recent months The National Institute of Health Care and Excellence (NICE) have released several key guidances on the use of AI in the UK. The recommendations made in these highlight the current position that many companies with AI technologies as a medical device (AIaMD) find themselves in. That is, a need to demonstrate why health systems need them. We take a look at why this is so important.

We hosted our second annual Healthtech Summit, bringing together a diverse community of healthtech leaders to share their stories and learn from each other.

Health technology suffered several setbacks the last few months, culminating with Pear Therapeutics recently filing for bankruptcy. Now it’s time to take stock, regroup and work to usher in the next generation of digital therapeutics.

AI-enabled health tech has had its share of ups and downs over the past few years. Hardian breaks down the obstacles and solutions to moving the space forward.